UniProtKB - Q9BQB4 (SOST_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Sclerostin
Gene
SOST
Organism
Homo sapiens (Human)
Status
Functioni
Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation.1 Publication
GO - Molecular functioni
- heparin binding Source: UniProtKB-KW
- transcription factor binding Source: UniProtKB
GO - Biological processi
- cellular response to parathyroid hormone stimulus Source: UniProtKB
- negative regulation of BMP signaling pathway Source: MGI
- negative regulation of canonical Wnt signaling pathway Source: BHF-UCL
- negative regulation of ossification Source: UniProtKB
- negative regulation of protein complex assembly Source: BHF-UCL
- negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification Source: BHF-UCL
- ossification Source: Ensembl
- positive regulation of transcription, DNA-templated Source: UniProtKB
- response to mechanical stimulus Source: UniProtKB
- Wnt signaling pathway Source: UniProtKB-KW
Keywordsi
| Molecular function | Heparin-binding |
| Biological process | Wnt signaling pathway |
Enzyme and pathway databases
| Reactomei | R-HSA-201681. TCF dependent signaling in response to WNT. R-HSA-3772470. Negative regulation of TCF-dependent signaling by WNT ligand antagonists. |
| SIGNORi | Q9BQB4. |
Names & Taxonomyi
| Protein namesi | Recommended name: Sclerostin |
| Gene namesi | Name:SOST ORF Names:UNQ2976/PRO7455/PRO7476 |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:13771. SOST. |
Subcellular locationi
- Secreted › extracellular space › extracellular matrix 1 Publication
GO - Cellular componenti
- extracellular region Source: Reactome
- extracellular space Source: Ensembl
- Golgi apparatus Source: Ensembl
- proteinaceous extracellular matrix Source: UniProtKB-SubCell
- protein complex Source: Ensembl
Keywords - Cellular componenti
Extracellular matrix, SecretedPathology & Biotechi
Involvement in diseasei
Sclerosteosis 1 (SOST1)3 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionAn autosomal recessive sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients.
See also OMIM:269500| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_063982 | 167 | C → R in SOST1; leads to retention of the mutant protein in the endoplasmic reticulum; leads to a complete loss of function of the protein. 1 Publication | 1 |
Van Buchem disease (VBCH)1 Publication
The disease is caused by mutations affecting the gene represented in this entry. A 52 kb deletion downstream of SOST results in SOST transcription suppression causing van Buchem disease.
Disease descriptionVBCH is an autosomal recessive sclerosing bone dysplasia characterized by endosteal hyperostosis of the mandible, skull, ribs, clavicles, and diaphyses of the long bones. Affected patients present a symmetrically increased thickness of bones, most frequently found as an enlarged jawbone, but also an enlargement of the skull, ribs, diaphysis of long bones, as well as tubular bones of hands and feet. The clinical consequence of increased thickness of the skull include facial nerve palsy causing hearing loss, visual problems, neurological pain, and, very rarely, blindness as a consequence of optic atrophy. Serum alkaline phosphatase levels are elevated.
See also OMIM:239100Craniodiaphyseal dysplasia autosomal dominant (CDD)1 Publication
The disease is caused by mutations affecting the gene represented in this entry. Heterozygous mutations located in the secretion signal of the SOST gene prevent sclerostin secretion and can be responsible for craniodiaphyseal dysplasia.
Disease descriptionA severe bone dysplasia characterized by massive generalized hyperostosis and sclerosis, especially involving the skull and facial bones. The sclerosis is so severe that the resulting facial distortion is referred to as 'leontiasis ossea' (leonine faces) and the bone deposition results in progressive stenosis of craniofacial foramina. Respiratory obstruction due to choanal stenosis compromises the clinical outcomes of affected patients.
See also OMIM:122860| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_065766 | 21 | V → L in CDD; affects protein secretion. 1 Publication | 1 | |
| Natural variantiVAR_065767 | 21 | V → M in CDD; de novo mutation; affects protein secretion. 1 PublicationCorresponds to variant dbSNP:rs387907169Ensembl. | 1 |
Keywords - Diseasei
Disease mutationOrganism-specific databases
| DisGeNETi | 50964. |
| MalaCardsi | SOST. |
| MIMi | 122860. phenotype. 239100. phenotype. 269500. phenotype. |
| OpenTargetsi | ENSG00000167941. |
| Orphaneti | 1513. Craniodiaphyseal dysplasia. 3416. Hyperostosis corticalis generalisata. 3152. Sclerosteosis. |
| PharmGKBi | PA37809. |
Chemistry databases
| ChEMBLi | CHEMBL3580487. |
Polymorphism and mutation databases
| BioMutai | SOST. |
| DMDMi | 20140220. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Signal peptidei | 1 – 23 | 1 PublicationAdd BLAST | 23 | |
| ChainiPRO_0000033177 | 24 – 213 | SclerostinAdd BLAST | 190 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Glycosylationi | 53 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Disulfide bondi | 80 ↔ 134 | 1 Publication | ||
| Disulfide bondi | 94 ↔ 148 | 1 Publication | ||
| Disulfide bondi | 105 ↔ 165 | 1 Publication | ||
| Disulfide bondi | 109 ↔ 167 | 1 Publication | ||
| Glycosylationi | 175 | N-linked (GlcNAc...) asparagineSequence analysis | 1 |
Keywords - PTMi
Disulfide bond, GlycoproteinProteomic databases
| PaxDbi | Q9BQB4. |
| PeptideAtlasi | Q9BQB4. |
| PRIDEi | Q9BQB4. |
Expressioni
Tissue specificityi
Widely expressed at low levels with highest levels in bone, cartilage, kidney, liver, bone marrow and primary osteoblasts differentiated for 21 days. Detected in the subendothelial layer of the aortic intima (at protein level).1 Publication
Gene expression databases
| Bgeei | ENSG00000167941. |
| CleanExi | HS_SOST. |
| Genevisiblei | Q9BQB4. HS. |
Organism-specific databases
| HPAi | CAB025660. |
Interactioni
Subunit structurei
Interacts with LRP4 (via the extracellular domain); the interaction facilitates the inhibition of Wnt signaling. Interacts with LRP5 (via the first two YWTD-EGF repeat domains); the interaction inhibits Wnt-mediated signaling. Interacts with LRP6.2 Publications
Binary interactionsi
GO - Molecular functioni
- transcription factor binding Source: UniProtKB
Protein-protein interaction databases
| BioGridi | 119186. 23 interactors. |
| DIPi | DIP-59407N. |
| IntActi | Q9BQB4. 99 interactors. |
| STRINGi | 9606.ENSP00000301691. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 78 – 80 | Combined sources | 3 | |
| Beta strandi | 82 – 87 | Combined sources | 6 | |
| Beta strandi | 95 – 98 | Combined sources | 4 | |
| Beta strandi | 100 – 105 | Combined sources | 6 | |
| Beta strandi | 139 – 147 | Combined sources | 9 | |
| Beta strandi | 155 – 162 | Combined sources | 8 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 2K8P | NMR | - | A | 25-213 | [»] | |
| 3SOV | X-ray | 1.27 | Z | 115-121 | [»] | |
| DisProti | DP00926. | |||||
| ProteinModelPortali | Q9BQB4. | |||||
| SMRi | Q9BQB4. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Miscellaneous databases
| EvolutionaryTracei | Q9BQB4. |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 82 – 172 | CTCKAdd BLAST | 91 |
Sequence similaritiesi
Belongs to the sclerostin family.Curated
Keywords - Domaini
SignalPhylogenomic databases
| eggNOGi | ENOG410IVV4. Eukaryota. ENOG4111KFN. LUCA. |
| GeneTreei | ENSGT00390000014900. |
| HOGENOMi | HOG000252934. |
| HOVERGENi | HBG003729. |
| InParanoidi | Q9BQB4. |
| KOi | K16834. |
| OMAi | DVSEYSC. |
| OrthoDBi | EOG091G13DX. |
| PhylomeDBi | Q9BQB4. |
| TreeFami | TF353019. |
Family and domain databases
| Gene3Di | 2.10.90.10. 1 hit. |
| InterProi | View protein in InterPro IPR006207. Cys_knot_C. IPR029034. Cystine-knot_cytokine. IPR008835. Sclerostin/SOSTDC1. IPR015665. SOST. |
| PANTHERi | PTHR14903. PTHR14903. 1 hit. PTHR14903:SF8. PTHR14903:SF8. 1 hit. |
| Pfami | View protein in Pfam PF05463. Sclerostin. 1 hit. |
| SMARTi | View protein in SMART SM00041. CT. 1 hit. |
Sequences (2)i
Sequence statusi: Complete.
Sequence processingi: The displayed sequence is further processed into a mature form.
This entry describes 2 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform 1 (identifier: Q9BQB4-1) [UniParc]FASTAAdd to basket
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MQLPLALCLV CLLVHTAFRV VEGQGWQAFK NDATEIIPEL GEYPEPPPEL
60 70 80 90 100
ENNKTMNRAE NGGRPPHHPF ETKDVSEYSC RELHFTRYVT DGPCRSAKPV
110 120 130 140 150
TELVCSGQCG PARLLPNAIG RGKWWRPSGP DFRCIPDRYR AQRVQLLCPG
160 170 180 190 200
GEAPRARKVR LVASCKCKRL TRFHNQSELK DFGTEAARPQ KGRKPRPRAR
210
SAKANQAELE NAY
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_065766 | 21 | V → L in CDD; affects protein secretion. 1 Publication | 1 | |
| Natural variantiVAR_065767 | 21 | V → M in CDD; de novo mutation; affects protein secretion. 1 PublicationCorresponds to variant dbSNP:rs387907169Ensembl. | 1 | |
| Natural variantiVAR_063982 | 167 | C → R in SOST1; leads to retention of the mutant protein in the endoplasmic reticulum; leads to a complete loss of function of the protein. 1 Publication | 1 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_010189 | 64 – 73 | RPPHHPFETK → WPGGRPPSRAPLST in isoform 2. 1 Publication | 10 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | AF331844 mRNA. Translation: AAK16158.1. AF326736 Genomic DNA. Translation: AAK13451.1. AF326739 mRNA. Translation: AAK13454.1. AY358203 mRNA. Translation: AAQ88570.1. AY358627 mRNA. Translation: AAQ88990.1. AC055813 Genomic DNA. No translation available. BC101086 mRNA. Translation: AAI01087.1. BC101087 mRNA. Translation: AAI01088.1. BC101088 mRNA. Translation: AAI01089.1. BC101089 mRNA. Translation: AAI01090.1. |
| CCDSi | CCDS11468.1. [Q9BQB4-1] |
| RefSeqi | NP_079513.1. NM_025237.2. [Q9BQB4-1] |
| UniGenei | Hs.349204. |
Genome annotation databases
| Ensembli | ENST00000301691; ENSP00000301691; ENSG00000167941. [Q9BQB4-1] |
| GeneIDi | 50964. |
| KEGGi | hsa:50964. |
| UCSCi | uc002iec.1. human. [Q9BQB4-1] |
Keywords - Coding sequence diversityi
Alternative splicingSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | SOST_HUMAN | |
| Accessioni | Q9BQB4Primary (citable) accession number: Q9BQB4 Secondary accession number(s): Q495N9 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | March 5, 2002 |
| Last sequence update: | June 1, 2001 | |
| Last modified: | May 10, 2017 | |
| This is version 141 of the entry and version 1 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Direct protein sequencing, Reference proteomeDocuments
- Human chromosome 17
Human chromosome 17: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - SIMILARITY comments
Index of protein domains and families
